Year Founded
2005
Ownership
Private
Employees
~10
Stage
Commercial
Modalities
Global Pharma Advisory General Information
Company faced significant FDA warning letter due to contaminated ophthalmic products that led to serious adverse events including vision loss and deaths. Multiple product recalls were initiated in 2023.
Contact Information
Drug Pipeline
Artificial Tears
CommercialKey Partnerships
EzriCare LLC, Delsam Pharma LLC
Global Pharma Advisory Funding
No funding data available
To view Global Pharma Advisory's complete valuation and funding history, request access »